María José Ruiz Cano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
María José Ruiz Cano has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Juan Francisco Delgado
Cardiology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28041 Madrid, Spain
5 shared publications - Carmen Jiménez López-Guarch
Servicio de Cardiología, Hospital Universitario 12 de Octubre, Madrid, Spain
3 shared publications Jan Gummert
Division of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW Bad Oeynhausen, Ruhr-University Bochum, Germany
3 shared publicationsMichiel Morshuis
Division of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW Bad Oeynhausen, Ruhr-University Bochum, Germany
3 shared publicationsPilar Escribano
3 shared publicationsVolker Lauenroth
Division of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW Bad Oeynhausen, Ruhr-University Bochum, Germany
3 shared publications
Latest Publications
- 1 August 2022
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 75 (8) , 626-635
Clinical findings associated with incomplete hemodynamic left ventricular unloading in patients with a left ventricular assist device
- 1 August 2022
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 75 (8) , 626-635
Clinical findings associated with incomplete hemodynamic left ventricular unloading in patients with a left ventricular assist device
- 30 March 2021
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 60 (1) , 177-185
Clinical implications of late-onset right ventricular failure after implantation of a continuous-flow left ventricular assist device as bridge to transplantation
OBJECTIVES: The development of late-onset right ventricular failure (LoRVF) that occurs months after a continuous-flow left ventricular assist device (LVAD) is implanted is a clinical problem that warrants investigation. Our goal was to study the incidence, clinical manifestations and prognosis of LoRVF in a population of patients who received an LVAD as bridge to transplantation. METHODS: Data were analysed from 97 consecutive patients who received an LVAD as bridge to transplantation and underwent a right heart catheterization at least 3 months after receiving an LVAD implantation. LoRVF was defined if both haemodynamic criteria of a central venous pressure >16 mmHg and a cardiac index <2.3 l/min/m2 were present. Clinical and echocardiographic variables, hospitalizations for heart failure and survival were compared between patients with and without LoRVF. RESULTS: LoRVF was diagnosed in 13% of patients after a median time of 11 months. Patients with LoRVF presented preoperative worse right ventricular (RV) dilatation and severe tricuspid regurgitation. LORVF was also associated with postoperative RV dilatation, moderate to severe tricuspid regurgitation and lower tricuspid annular plane systolic excursion. LoRVF resulted in increased brain natriuretic peptide levels and the need for diuretics, lower haemoglobin levels and a higher rate of atrial fibrillation and gastrointestinal bleeding. The rate of hospitalizations for heart failure in patients with LoRVF was 46%, and 15% required an urgent transplantation due to refractory RV failure. LoRVF decreased global survival and survival free from hospitalizations for heart failure (P < 0.0001). CONCLUSIONS: LoRVF after the implantation of an LVAD as bridge to transplantation is associated with higher morbidity and lower survival. The results suggest that the routine use of a right heart catheterization and transthoracic echocardiography may contribute to an early diagnosis before further severe complications due to refractory RV failure might occur. ID number of the IRB approval: AZ-2019-521 on 10 July 2019.
- 30 March 2021
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 60 (1) , 177-185
Clinical implications of late-onset right ventricular failure after implantation of a continuous-flow left ventricular assist device as bridge to transplantation
OBJECTIVES: The development of late-onset right ventricular failure (LoRVF) that occurs months after a continuous-flow left ventricular assist device (LVAD) is implanted is a clinical problem that warrants investigation. Our goal was to study the incidence, clinical manifestations and prognosis of LoRVF in a population of patients who received an LVAD as bridge to transplantation. METHODS: Data were analysed from 97 consecutive patients who received an LVAD as bridge to transplantation and underwent a right heart catheterization at least 3 months after receiving an LVAD implantation. LoRVF was defined if both haemodynamic criteria of a central venous pressure >16 mmHg and a cardiac index <2.3 l/min/m2 were present. Clinical and echocardiographic variables, hospitalizations for heart failure and survival were compared between patients with and without LoRVF. RESULTS: LoRVF was diagnosed in 13% of patients after a median time of 11 months. Patients with LoRVF presented preoperative worse right ventricular (RV) dilatation and severe tricuspid regurgitation. LORVF was also associated with postoperative RV dilatation, moderate to severe tricuspid regurgitation and lower tricuspid annular plane systolic excursion. LoRVF resulted in increased brain natriuretic peptide levels and the need for diuretics, lower haemoglobin levels and a higher rate of atrial fibrillation and gastrointestinal bleeding. The rate of hospitalizations for heart failure in patients with LoRVF was 46%, and 15% required an urgent transplantation due to refractory RV failure. LoRVF decreased global survival and survival free from hospitalizations for heart failure (P < 0.0001). CONCLUSIONS: LoRVF after the implantation of an LVAD as bridge to transplantation is associated with higher morbidity and lower survival. The results suggest that the routine use of a right heart catheterization and transthoracic echocardiography may contribute to an early diagnosis before further severe complications due to refractory RV failure might occur. ID number of the IRB approval: AZ-2019-521 on 10 July 2019.
- Open Access
- 19 June 2020
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 35 (8) , 1832-1839
Risk factors of early right ventricular failure in patients undergoing LVAD implantation with intermediate Intermacs profile for advanced heart failure
Background The clinical profile of left ventricular assist device (LVAD) candidates is rapidly changing, with increasing proportion of patients in more stable clinical conditions. However, early postoperative right ventricular failure (eRVF) is still one of the cornerstones associated with increased mortality and the preoperative recognition of associated risk factors remains challenging. The aim of this study was to identify predictive parameters for eRVF after LVAD implantation in patients with preoperative intermediate Intermacs (InM) risk profile 3‐5. Methods Preoperative laboratory, echocardiography, and right heart catheterization data collected from 80 patients with InM profile 3‐5 before LVAD implantation were retrospectively tested with respect to their ability to predict the risk for eRVF after the implantation of a continuous‐flow LVAD. Results Preoperative higher bilirubin and blood urea nitrogen (BUN) levels, higher Model for End‐stage Liver Disease score, lower estimated glomerular filtration rate, and higher central venous pressure to pulmonary capillary wedge pressure ratio (CVP/PCWP) were associated to higher risk of eRVF. Regarding the echocardiographic assessment, higher end diastolic linear dimensions of the RV, higher basal end diastolic RV linear dimension to LV ratio, severe tricuspid regurgitation, lower tricuspid annular plane systolic excursion, and lower RV fractional area contraction identified patients with higher risk for eRVF. In the multivariable analysis, a CVP/CPWP > 0.55 (odds ratio [OR]: 4, 95% confidence interval [CII]: 1.4‐11.8;P = .01) and BUN > 44.5 mg/dL (OR: 6.6, 95% CI: 1.51‐23; P = .011) independently predicted the risk of eRVF. Conclusion Preoperative BUN > 44.5 mg/dL and CVP/PCWP > 0.55 are associated to an increased risk of eRVF following LVAD implantation in intermediate InM patients.
- 19 June 2020
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 35 (8) , 1832-1839
Open AccessRisk factors of early right ventricular failure in patients undergoing LVAD implantation with intermediate Intermacs profile for advanced heart failure
Background The clinical profile of left ventricular assist device (LVAD) candidates is rapidly changing, with increasing proportion of patients in more stable clinical conditions. However, early postoperative right ventricular failure (eRVF) is still one of the cornerstones associated with increased mortality and the preoperative recognition of associated risk factors remains challenging. The aim of this study was to identify predictive parameters for eRVF after LVAD implantation in patients with preoperative intermediate Intermacs (InM) risk profile 3‐5. Methods Preoperative laboratory, echocardiography, and right heart catheterization data collected from 80 patients with InM profile 3‐5 before LVAD implantation were retrospectively tested with respect to their ability to predict the risk for eRVF after the implantation of a continuous‐flow LVAD. Results Preoperative higher bilirubin and blood urea nitrogen (BUN) levels, higher Model for End‐stage Liver Disease score, lower estimated glomerular filtration rate, and higher central venous pressure to pulmonary capillary wedge pressure ratio (CVP/PCWP) were associated to higher risk of eRVF. Regarding the echocardiographic assessment, higher end diastolic linear dimensions of the RV, higher basal end diastolic RV linear dimension to LV ratio, severe tricuspid regurgitation, lower tricuspid annular plane systolic excursion, and lower RV fractional area contraction identified patients with higher risk for eRVF. In the multivariable analysis, a CVP/CPWP > 0.55 (odds ratio [OR]: 4, 95% confidence interval [CII]: 1.4‐11.8;P = .01) and BUN > 44.5 mg/dL (OR: 6.6, 95% CI: 1.51‐23; P = .011) independently predicted the risk of eRVF. Conclusion Preoperative BUN > 44.5 mg/dL and CVP/PCWP > 0.55 are associated to an increased risk of eRVF following LVAD implantation in intermediate InM patients.
- 26 April 2017
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 70 (11) , 915-923
Trends in Pulmonary Hypertension Over a Period of 30 Years: Experience From a Single Referral Centre
- 26 April 2017
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 70 (11) , 915-923
Trends in Pulmonary Hypertension Over a Period of 30 Years: Experience From a Single Referral Centre
- 1 February 2015
- Published by Elsevier in International Journal of Cardiology
- Vol. 181, 232-234
The distribution of the obstruction in the pulmonary arteries modifies pulsatile right ventricular afterload in pulmonary hypertension
- 1 February 2015
- Published by Elsevier in International Journal of Cardiology
- Vol. 181, 232-234
The distribution of the obstruction in the pulmonary arteries modifies pulsatile right ventricular afterload in pulmonary hypertension
- Open Access
- 21 October 2011
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 11 (1) , 64
Giant pulmonary artery aneurysm in a patient with vasoreactive pulmonary hypertension: a case report
Pulmonary artery aneurysms are a rare condition, frequently associated with pulmonary hypertension. However, the evolution and treatment of this pathology is still not clear.
- 21 October 2011
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 11 (1) , 64
Open AccessGiant pulmonary artery aneurysm in a patient with vasoreactive pulmonary hypertension: a case report
Pulmonary artery aneurysms are a rare condition, frequently associated with pulmonary hypertension. However, the evolution and treatment of this pathology is still not clear.
- 2 June 2008
- Published by Wiley in The Clinical Respiratory Journal
- Vol. 2 (3) , 191-192
Different features of pulmonary hypertension in Rendu–Osler Syndrome
- 2 June 2008
- Published by Wiley in The Clinical Respiratory Journal
- Vol. 2 (3) , 191-192
Different features of pulmonary hypertension in Rendu–Osler Syndrome
- 1 November 2006
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 25 (11) , 1353-1357
Efficacy of Sildenafil as a Rescue Therapy for Patients With Severe Pulmonary Arterial Hypertension and Given Long-term Treatment With Prostanoids: 2-Year Experience
- 1 November 2006
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 25 (11) , 1353-1357
Efficacy of Sildenafil as a Rescue Therapy for Patients With Severe Pulmonary Arterial Hypertension and Given Long-term Treatment With Prostanoids: 2-Year Experience